SPONSORED CONTENT

Research protocol on Ayurvedic treatment of COVID-19 by team of doctors from Pune, published in reputed international journal

December 10, 2020 23:30 IST
Tennis player James Blake
ACE Hospital

Pune (Maharashtra) [India], December 10 (ANI/BusinessWire India): A paper on an ayurvedic protocol designed by a team of doctors from Pune led by Dr Suresh Patankar has been published in a reputed international journal.

This could be the first instance where Nature's Trial Journal which is internationally accepted for validated publications in medical research, has published an Ayurvedic protocol. The journal committee of Savitribai Phule Pune University too has testified to this. This endorses the fact that, with due efforts, in the current times, ayurvedic science can easily prove to be evidence based.

The science of ayurveda mentions several remedies that could be used during a pandemic/epidemic. As there are no test parameters according to modern medicine that could validate these medicines/constituents, such medicinal constituents did not get necessary/authorized approvals. Also, most of the time clinical trials based on modern test parameters have not been conducted on such medicines.

Under such circumstances the AMAI Trust and Ace Hospital, Pune took the challenge head on. The institutions since the past few years were already engaged in research on medicines of a similar kind. Many subjects were found to benefit by these medicines.

A team of doctors was constituted under the guidance of Dr. Suresh Patankar. This team comprised of Vd. Hrishikesh Rangnekar, physician Dr Kishore Suryawanshi, Dr Praveen Soni, immunity specialist Dr Kalpana Joshi and immunity scientist Dr Tejas Shah. This team designed the clinical trial protocol for the treatment of COVID-19 patients.

This protocol includes almost all the internationally/globally applicable test parameters. This included tests for Viral Load (wherein the exact number of viral counts in an infected individual is determined. This test is completely different than the currently conducted RT-PCR or CT Value tests), TCell (th-1, th-2, th-17 ils-6), NK Cell, IGG, IGM, B Lymphocytes, Antibodies, D Dimer and many others.

To have such a kind of Ayush protocol on Corona published in Nature's Trial Journal is a matter of great joy. This also highlights the necessity of applying modern test parameters while conducting research in ayurveda or Ayush.

This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article. (ANI/BusinessWire India)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Research protocol on Ayurvedic treatment of COVID-19 by team of doctors from Pune, published in reputed international journal

Pune (Maharashtra) [India], December 10 (ANI/BusinessWire India): A paper on an ayurvedic protocol designed by a team of doctors from Pune led by Dr Suresh Patankar has been published in a reputed international journal.

This could be the first instance where Nature's Trial Journal which is internationally accepted for validated publications in medical research, has published an Ayurvedic protocol. The journal committee of Savitribai Phule Pune University too has testified to this. This endorses the fact that, with due efforts, in the current times, ayurvedic science can easily prove to be evidence based.

The science of ayurveda mentions several remedies that could be used during a pandemic/epidemic. As there are no test parameters according to modern medicine that could validate these medicines/constituents, such medicinal constituents did not get necessary/authorized approvals. Also, most of the time clinical trials based on modern test parameters have not been conducted on such medicines.

Under such circumstances the AMAI Trust and Ace Hospital, Pune took the challenge head on. The institutions since the past few years were already engaged in research on medicines of a similar kind. Many subjects were found to benefit by these medicines.

A team of doctors was constituted under the guidance of Dr. Suresh Patankar. This team comprised of Vd. Hrishikesh Rangnekar, physician Dr Kishore Suryawanshi, Dr Praveen Soni, immunity specialist Dr Kalpana Joshi and immunity scientist Dr Tejas Shah. This team designed the clinical trial protocol for the treatment of COVID-19 patients.

This protocol includes almost all the internationally/globally applicable test parameters. This included tests for Viral Load (wherein the exact number of viral counts in an infected individual is determined. This test is completely different than the currently conducted RT-PCR or CT Value tests), TCell (th-1, th-2, th-17 ils-6), NK Cell, IGG, IGM, B Lymphocytes, Antibodies, D Dimer and many others.

To have such a kind of Ayush protocol on Corona published in Nature's Trial Journal is a matter of great joy. This also highlights the necessity of applying modern test parameters while conducting research in ayurveda or Ayush.

This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article. (ANI/BusinessWire India)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22